Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-15-Speech-2-582-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-15"^^xsd:date2
dcterms:Is Part Of	lp_eu:Falsified medicinal products (debate)2
dcterms:Language	"sv"^^xsd:language2
lpv:document identification number	"en.20110215.29.2-582-000"2
lpv:hasSubsequent	lp_eu:2011-02-15-Speech-2-583-0002
lpv:speaker	lp:Åsa Westlund2
lpv:spokenAs	member; S&D (2009-07-14--2014-06-30)3 substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; DEVE (2009-07-16--2012-01-18)3 member; ENVI (2009-07-16--2012-01-18)3 unknown; Arbetarepartiet- Socialdemokraterna (2009-07-14--2014-06-30)3
lpv:translated text	"Madam President, I would like to thank Commissioner Dalli, the rapporteur, Mrs Matias, and the shadow rapporteurs for their excellent work on an important matter, because falsified medicinal products clearly represent a serious threat to patients’ health. What is particularly serious is the fact that the number of falsifications of life-saving medicines is increasing. These are medicines for the treatment of cancer, heart disease and infections, in other words, situations where someone really is in need of an effective medicine. We are now taking a major step forward with regard to medicinal products within the EU, but the problem extends beyond the EU’s borders. According to the WHO’s expert group, many countries in Africa, parts of Asia and Latin America have areas where more than 30% of the medicines on sale may be falsified. It is therefore extremely important for cooperation with third countries to be strengthened, and hopefully the changes that we are now implementing within the EU will also have an impact on the countries outside our Union."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph